Skip to main content
Springer logoLink to Springer
. 2021 Mar 31;40(4):450–453. doi: 10.1007/s10930-021-09981-w

Miguel Llinás and the Structure of the Kringle Fold

Laszlo Patthy 1,
PMCID: PMC8373733  PMID: 33791899

The mid-1970s and early 1980s have witnessed a burst of interest in fibrinolytic proteases as it became clear, primarily through the pioneering work of Edward Reich and his coworkers (The Rockefeller University) that these enzymes might play an important role in tumor invasion and metastasis [15]. The observation that oncogenic transformation leads to loss of fibronectin and reduced adhesion of tumor cells, the hypothesis that loss of fibronectin is due to its proteolytic degradation, have further increased interest in the role of extracellular matrix proteins and proteases in tumor metastasis [6, 7].

The first major advances in the structural biology of fibrinolytic enzymes and fibronectin were made by the laboratory of Staffan Magnusson (University of Aarhus). Magnusson and coworkers have determined the primary sequence of plasminogen and have shown that five regions in the non-protease part of this protein show significant sequence homology with two internally homologous structures of prothrombin [810]. They have used the term kringle for these homologous regions since the two dimensional representation of their disulfide-bridged structures resemble the classical shape of this Scandinavian cake [810]. The Magnusson lab has also determined the primary sequence of fibronectin. This large protein was found to have three types of internal homology regions (type I, type II and type III repeats), indicating that a number of partial internal gene duplications have occurred during the evolution of this multidomain protein [11, 12].

Our research group was attracted to this field at the end of the 70s with a view of clarifying structure-function aspects of plasminogen, plasminogen activators and fibronectin, focusing on kringles of plasminogen and the three types of internal homology units of fibronectin. We have demonstrated that the kringle 5 domain of human plasminogen carries a benzamidine-binding site [13], but we focused primarily on kringles 1 and 4 that were known to be responsible for the lysine-affinity of plasminogen. Based on chemical modification studies, we have demonstrated that the primary determinants of the lysine-binding site of kringle 4 are Arginine 70 and Aspartic acid 56 that provide the positive and negative charges necessary for electrostatic binding of the ligand’s carboxylate and ammonium groups [14]. In the case of kringle 1 domain of plasminogen, we have shown that Arginines 32 and 34 are essential for the fibrin affinity of this domain [15]. Parallel with these structure-function studies, at the suggestion of Robert Williams (University of Oxford) we have started a collaboration to solve the solution structure of kringle 4 by NMR spectroscopy. Comparison of the NMR spectrum of kringle 4 with the spectra of various kringle 4 species chemically modified at defined positions has permitted the assignment of several resonances to specific residues in the kringle 4 sequence [16, 17]. The NOE studies on kringle 4 revealed that Leucine 45 is in close proximity of the sequentially distant Trp25/Trp61 residue pair, delineating a key structural feature of the kringle-fold. The binding of 6-aminohexanoic acid to kringle 4 was shown to cause shifts in the resonances of Trp71 (neighboring the ligand-binding Arginine 70), suggesting that it may be lining the ω-aminocarboxylic acid binding site of the kringle. This localization of the binding site was in harmony with the result of Hochschwender and Laursen that modification of Trp71 results in loss of ligand affinity of kringle 4 [18].

During the course of these studies we have become aware of the collaborative efforts of the lab of Richard Laursen (Boston University) and the lab of Miguel Llinás (Carnegie-Mellon University) to study the structure of plasminogen kringles by NMR spectroscopy [1921]. In agreement with Robert Williams, we have decided to join forces, rather than duplicate efforts on kringle 4 [22]. We have participated in a collaboration with Miguel in a comparative study of human, porcine, bovine and chicken kringle 4 domains that has significantly facilitated resonance assignment [2325]. Miguel continued his impressive NMR studies on kringle 1and kringle 4 of plasminogen with the Laursen lab [2632], but he has also extended his studies to kringle 3 [33] and kringle 5 of plasminogen [3437], the kringle 2 domain of the tissue-type plasminogen activator [3841] and the kringle of urokinase [42, 43], making him an unquestionable authority on kringles.

In the late 1980s the focus of our research has moved to other fields, therefore our work on kringles and our collaboration with Miguel, temporarily, has ended in 1988. We have, however, learned an important lesson from our studies on kringles: the conservation of residues in different, non-orthologous kringles reflects their relative importance for the folding autonomy of kringle fold [44]. In this respect, it was noteworthy that the most highly conserved Trp25, Leucine 45 and Trp61 residues of kringles interact to form the core of the kringle-fold [16]. In other words, since the acceptance of mutations in a fold family depends on the role and importance of the affected residues in the protein fold, the pattern of conserved residues, variable sequences, regions that tolerate gap events etc. are characteristic of a protein fold. Accordingly, ‘consensus sequences’ incorporating these features may be used to decide whether a sequence has the features typical of the given protein fold, therefore they may be used to detect distant homologies [45]. The application of this principle allowed us to detect numerous “surprising” homologies, some of which were relevant for both fibronectin and the proteases of the fibrinolytic system. For example, we have demonstrated that the type I repeats (finger domains) of fibronectin are homologous with a domain of tissue-type plasminogen activator [46], whereas the type II repeats present in the gelatin-binding region of fibronectin are homologous with the kringle domains of proteases [47].

The latter finding has led us to initiate a new round of collaboration with Miguel’s group, this time on fibronectin type II repeats. Initially, the primary goal of this collaboration was to explore whether the distant homology of type II units and kringles is supported by their structural and functional similarities. In the first part of our work, we have studied a type II domain of the collagen binding bovine seminal fluid protein PDC-109, resulting in the first structure of a type II domain [4850].

Our project on type II domains, however, gained additional interest when it turned out that gelatinases also contain type II domains. These metalloproteases play a key role in matrix remodeling, degradation of basement membranes and contribute significantly to the metastatic potential of tumor cells; they appeared promising targets for tumor therapy. Significantly, the three tandem type II domains of gelatinase A were shown to be responsible for the high affinity of the enzyme for collagen [51].

The NMR spectroscopic studies of Miguel on the various type II domains of gelatinase A [5258] have provided important insight into the structure and function of these collagen-binding modules. These studies confirmed that kringle modules and fibronectin type II modules are related both in structure and function. This conclusion is now generally accepted; according to SCOP classification (http://scop.mrc-lmb.cam.ac.uk), kringle modules and fibronectin type II modules represent two families of the kringle-like superfamily.

Although our collaboration with Miguel Llinás was primarily through exchange of research materials via mail, exchanging ideas via email, we had regular personal contacts at the biannual meetings of the International Society for Fibrinolysis & Proteolysis (that has a kringle image in its logo) or at the various Plasminogen Activator workshops. I enjoyed his company as he had a good sense of humor, appreciated the pleasant aspects of life and had a broad interest in culture, history, music. He was an admirer of Bartók so I am glad that when he visited us in Hungary, I could show him the Béla Bartók Memorial House to get an impression about the life of this genius.

With Miguel’s passing, science has lost a dedicated scientist and I have lost one of the best friends I acquainted with during the heydays of Plasminogen Activation research.

Funding

Open access funding provided by ELKH Research Centre for Natural Sciences.. Funding was provided by the National Research, Development and Innovation Office of Hungary (Grant GINOP-2.3.2-15-2016-00001).

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Ossowski L, Quigley JP, Kellerman GM, Reich E. Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med. 1973;138:1056–1064. doi: 10.1084/jem.138.5.1056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Unkeless J, Dano K, Kellerman GM, Reich E. Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator. J Biol Chem. 1974;249:4295–4305. [PubMed] [Google Scholar]
  • 3.Quigley JP, Ossowski L, Reich E. Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem. 1974;249:4306–4311. [PubMed] [Google Scholar]
  • 4.Ossowski L, Quigley JP, Reich E. Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem. 1974;249:4312–4320. [PubMed] [Google Scholar]
  • 5.Jones P, Benedict W, Strickland S, Reich E. Fibrin overlay methods for the detection of single transformed cells and colonies of transformed cells. Cell. 1975;5:323–329. doi: 10.1016/0092-8674(75)90108-7. [DOI] [PubMed] [Google Scholar]
  • 6.Hynes RO, Yamada KM. Fibronectins: multifunctional modular glycoproteins. J Cell Biol. 1982;95:369–377. doi: 10.1083/jcb.95.2.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Vartio T, Vaheri A. Fibronectin: chains of domains with diversified functions. Trends Biochem Sci. 1983;8:442–444. [Google Scholar]
  • 8.Magnusson S, Petersen TE, Sottrup Jensen L, Claeys H. Complete primary structure of prothrombin: isolation, structure and reactivity of ten carbosylated glutamic acid residues and regulation of prothrombin activation by thrombin. In: Reich E, Rifkin DB, Shaw E, editors. Proteases and biological control. New York: Cold Spring Harbor Laboratory; 1975. pp. 123–149. [Google Scholar]
  • 9.Claeys H, Sottrup-Jensen L, Zajdel M, Petersen TE, Magnusson S. Multiple gene duplication in the evolution of plasminogen. Five regions of sequence homology with the two internally homologous structures in prothrombin. FEBS Lett. 1976;61:20–24. doi: 10.1016/0014-5793(76)80161-5. [DOI] [PubMed] [Google Scholar]
  • 10.Sottrup Jensen L, Claeys H, Zajdel M, Petersen TE, Magnusson S. The primary structure of human plasminogen: isolation of two lysine-binding fragments and one mini-plasminogen (MW; 38, 000) by elastase-catalyzed-specific limited proteolysis. In: Davidson JF, Rowan RM, Samama MM, Desnoyers PC, editors. Progress in chemical fibrinolysis and thrombolysis. New York: Raven Press; 1978. pp. 191–209. [Google Scholar]
  • 11.Skorstengaard K, Thøgersen HC, Vibe-Pedersen K, Petersen TE, Magnusson S. Purification of twelve cyanogen bromide fragments from bovine plasma fibronectin and the amino acid sequence of eight of them. Overlap evidence aligning two plasmic fragments, internal homology in gelatin-binding region and phosphorylation site near C terminus. Eur J Biochem. 1982;128:605–623. doi: 10.1111/j.1432-1033.1982.tb07007.x. [DOI] [PubMed] [Google Scholar]
  • 12.Petersen TE, Thøgersen HC, Skorstengaard K, Vibe-Pedersen K, Sahl P, Sottrup-Jensen L, Magnusson S. Partial primary structure of bovine plasma fibronectin: three types of internal homology. Proc Natl Acad Sci USA. 1983;80:137–141. doi: 10.1073/pnas.80.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Váradi A, Patthy L. Kringle 5 of human plasminogen carries a benzamidine-binding site. Biochem Biophys Res Commun. 1981;103:97–102. doi: 10.1016/0006-291x(81)91665-x. [DOI] [PubMed] [Google Scholar]
  • 14.Trexler M, Váli Z, Patthy L. Structure of the omega-aminocarboxylic acid-binding sites of human plasminogen. Arginine 70 and aspartic acid 56 are essential for binding of ligand by kringle 4. J Biol Chem. 1982;257:7401–7406. [PubMed] [Google Scholar]
  • 15.Váli Z, Patthy L. The fibrin-binding site of human plasminogen. Arginines 32 and 34 are essential for fibrin affinity of the kringle 1 domain. J Biol Chem. 1984;259:13690–13694. [PubMed] [Google Scholar]
  • 16.Trexler M, Bányai L, Patthy L, Pluck ND, Williams RJP. The solution structure of kringle 4. NMR studies on native and several chemically modified kringle 4 species of human plasminogen. FEBS Lett. 1983;154:311–318. [Google Scholar]
  • 17.Trexler M, Bányai L, Patthy L, Pluck ND, Williams RJP. Chemical modification and nuclear magnetic resonance studies on human plasminogen kringle 4. Assignment of tyrosine and histidine resonances to specific residues in the sequence. Eur J Biochem. 1985;152:439–446. doi: 10.1111/j.1432-1033.1985.tb09216.x. [DOI] [PubMed] [Google Scholar]
  • 18.Hochschwender SM, Laursen RA. The lysine binding sites of human plasminogen. Evidence for a critical tryptophan in the binding site of kringle 4. J Biol Chem. 1981;256:11172–11176. [PubMed] [Google Scholar]
  • 19.De Marco A, Hochschwender SM, Laursen RA, Llinás M. Human plasminogen. Proton NMR studies on kringle 1. J Biol Chem. 1982;257:12716–12721. [PubMed] [Google Scholar]
  • 20.Llinas M, De Marco A, Hochschwender SM, Laursen RA. A 1H-NMR study of isolated domains from human plasminogen. Structural homology between kringles 1 and 4. Eur J Biochem. 1983;135:379–391. doi: 10.1111/j.1432-1033.1983.tb07665.x. [DOI] [PubMed] [Google Scholar]
  • 21.Hochschwender SM, Laursen RA, De Marco A, Llinas M. 600 MHz H nuclear magnetic resonance studies of the kringle 4 fragment of human plasminogen. Arch Biochem Biophys. 1983;223:58–67. doi: 10.1016/0003-9861(83)90571-4. [DOI] [PubMed] [Google Scholar]
  • 22.De Marco A, Pluck ND, Bányai L, Trexler M, Laursen RA, Patthy L, Llinás M, Williams RJ. Analysis and identification of aromatic signals in the proton magnetic resonance spectrum of the kringle 4 fragment from human plasminogen. Biochemistry. 1985;24:748–753. doi: 10.1021/bi00324a032. [DOI] [PubMed] [Google Scholar]
  • 23.Ramesh V, Gyenes M, Patthy L, Llinas M. The aromatic 1H-NMR spectrum of plasmninogen kringle 4: a comparative study of human, porcine and bovine homologs. Eur J Biochem. 1986;159:581–595. doi: 10.1111/j.1432-1033.1986.tb09925.x. [DOI] [PubMed] [Google Scholar]
  • 24.Petros AM, Gyenes M, Patthy L, Llinas M. Analysis of the aromatic 1H-NMR spectrum of chicken plasminogen kringle 4. Arch Biochem Biophys. 1988;264:192–202. doi: 10.1016/0003-9861(88)90585-1. [DOI] [PubMed] [Google Scholar]
  • 25.Petros AM, Gyenes M, Patthy L, Llinas M. Analysis of the aliphathic 1H-NMR spectrum of plasminogen kringle 4: a comparative study of human, porcine, bovine and chicken homologs. Eur J Biochem. 1988;170:549–563. doi: 10.1111/j.1432-1033.1988.tb13734.x. [DOI] [PubMed] [Google Scholar]
  • 26.De Marco A, Motta A, Llinás M, Laursen RA. Macro- and micro-stabilities of the kringle 4 domain from plasminogen. The effect of ligand binding. Biophys J. 1985;48:411–422. doi: 10.1016/S0006-3495(85)83797-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.De Marco A, Laursen RA, Llinás M. Proton Overhauser experiments on kringle 4 from human plasminogen. Implications for the structure of the kringles’ hydrophobic core. Biochim Biophys Acta. 1985;827:369–380. doi: 10.1016/0167-4838(85)90221-3. [DOI] [PubMed] [Google Scholar]
  • 28.De Marco A, Laursen RA, Llinas M. 1H-NMR spectroscopic manifestations of ligand binding to the kringle 4 domain of human plasminogen. Arch Biochem Biophys. 1986;244:727–741. doi: 10.1016/0003-9861(86)90642-9. [DOI] [PubMed] [Google Scholar]
  • 29.Motta A, Laursen RA, Rajan N, Llinás M. Proton magnetic resonance study of kringle 1 from human plasminogen. Insights into the domain structure. J Biol Chem. 1986;261:13684–13692. [PubMed] [Google Scholar]
  • 30.Motta A, Laursen RA, Llinás M. Characterization of the low-field proton magnetic resonance spectrum of plasminogen kringle 4 via selective Overhauser experiments in 1H2O. Biochemistry. 1986;25:7924–7931. doi: 10.1021/bi00372a021. [DOI] [PubMed] [Google Scholar]
  • 31.De Marco A, Petros AM, Laursen RA, Llinás M. Analysis of ligand-binding to the kringle 4 fragment from human plasminogen. Eur Biophys J. 1987;14:359–368. doi: 10.1007/BF00262321. [DOI] [PubMed] [Google Scholar]
  • 32.Motta A, Laursen RA, Llinás M, Tulinsky A, Park CH. Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen: structure of the ligand-binding site. Biochemistry. 1987;26:3827–3836. doi: 10.1021/bi00387a014. [DOI] [PubMed] [Google Scholar]
  • 33.Christen MT, Frank P, Schaller J, Llinás M. Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape. Biochemistry. 2010;49:7131–7150. doi: 10.1021/bi100687f. [DOI] [PubMed] [Google Scholar]
  • 34.Thewes T, Ramesh V, Simplaceanu EL, Llinás M. Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen. Biochim Biophys Acta. 1987;912:254–269. doi: 10.1016/0167-4838(87)90096-3. [DOI] [PubMed] [Google Scholar]
  • 35.Thewes T, Ramesh V, Simplaceanu EL, Llinás M. Analysis of the aromatic 1H-NMR spectrum of the kringle 5 domain from human plasminogen. Evidence for a conserved kringle fold. Eur J Biochem. 1988;175:237–249. doi: 10.1111/j.1432-1033.1988.tb14189.x. [DOI] [PubMed] [Google Scholar]
  • 36.Thewes T, Constantine K, Byeon IJ, Llinás M. Ligand interactions with the kringle 5 domain of plasminogen. A study by 1H NMR spectroscopy. J Biol Chem. 1990;265:3906–3915. [PubMed] [Google Scholar]
  • 37.Battistel MD, Grishaev A, An SS, Castellino FJ, Llinás M. Solution structure and functional characterization of human plasminogen kringle 5. Biochemistry. 2009;48:10208–10219. doi: 10.1021/bi901433n. [DOI] [PubMed] [Google Scholar]
  • 38.Byeon IJ, Kelley RF, Llinás M. 1H NMR structural characterization of a recombinant kringle 2 domain from human tissue-type plasminogen activator. Biochemistry. 1989;28:9350–9360. doi: 10.1021/bi00450a016. [DOI] [PubMed] [Google Scholar]
  • 39.Byeon IJ, Kelley RF, Llinás M. Kringle-2 domain of the tissue-type plasminogen activator. 1H-NMR assignments and secondary structure. Eur J Biochem. 1991;197:155–165. doi: 10.1111/j.1432-1033.1991.tb15894.x. [DOI] [PubMed] [Google Scholar]
  • 40.Byeon IJ, Llinás M. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug. J Mol Biol. 1991;222:1035–1051. doi: 10.1016/0022-2836(91)90592-t. [DOI] [PubMed] [Google Scholar]
  • 41.Byeon IJ, Kelley RF, Mulkerrin MG, An SS, Llinás M. Ligand binding to the tissue-type plasminogen activator kringle 2 domain: structural characterization by 1H-NMR. Biochemistry. 1995;34:2739–2750. doi: 10.1021/bi00009a002. [DOI] [PubMed] [Google Scholar]
  • 42.Bokman AM, Jiménez-Barbero J, Llinás M. 1H NMR characterization of the urokinase kringle module. Structural, but not functional, relatedness to homologous domains. J Biol Chem. 1993;268:13858–13868. [PubMed] [Google Scholar]
  • 43.Li X, Bokman AM, Llinás M, Smith RA, Dobson CM. Solution structure of the kringle domain from urokinase-type plasminogen activator. J Mol Biol. 1994;235:1548–1559. doi: 10.1006/jmbi.1994.1106. [DOI] [PubMed] [Google Scholar]
  • 44.Trexler M, Patthy L. Folding autonomy of the kringle 4 fragment of human plasminogen. Proc Natl Acad Sci U S A. 1983;80:2457–2461. doi: 10.1073/pnas.80.9.2457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Patthy L. Detecting homology of distantly related proteins with consensus sequences. J Mol Biol. 1987;198:567–577. doi: 10.1016/0022-2836(87)90200-2. [DOI] [PubMed] [Google Scholar]
  • 46.Bányai L, Váradi A, Patthy L. Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator. FEBS Lett. 1983;163:37–41. doi: 10.1016/0014-5793(83)81157-0. [DOI] [PubMed] [Google Scholar]
  • 47.Patthy L, Trexler M, Váli Z, Bányai L, Váradi A. Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases. FEBS Lett. 1984;171:131–136. doi: 10.1016/0014-5793(84)80473-1. [DOI] [PubMed] [Google Scholar]
  • 48.Bányai L, Trexler M, Koncz S, Gyenes M, Sipos Gy, Patthy L. The collagen-binding site of type II units of PDC-109 and fibronectin. Eur J Biochem. 1990;193:801–806. doi: 10.1111/j.1432-1033.1990.tb19403.x. [DOI] [PubMed] [Google Scholar]
  • 49.Constantine KL, Ramesh V, Bányai L, Trexler M, Patthy L, Llinas M. Sequence specific H-NMR assignments and structural characterization of bovine seminal fluid protein PDC-109 domain b. Biochemistry. 1991;30:1663–1672. doi: 10.1021/bi00220a032. [DOI] [PubMed] [Google Scholar]
  • 50.Constantine KL, Madrid M, Banyai L, Trexler M, Patthy L, Llinas M. Refined solution structure and ligand-binding properties of PDC-109 domain b. A collagen-binding type II domain. J Mol Biol. 1992;223:281–298. doi: 10.1016/0022-2836(92)90731-x. [DOI] [PubMed] [Google Scholar]
  • 51.Bányai L, Patthy L. Evidence for the involvement of type II domains in collagen binding by 72 kDa type IV procollagenase. FEBS Lett. 1991;282:23–25. doi: 10.1016/0014-5793(91)80436-7. [DOI] [PubMed] [Google Scholar]
  • 52.Briknarova K, Grishaev A, Bányai L, Tordai H, Patthy L, Llinas M. The second type II module from human matrix metalloproteinase 2: structure function and dynamics. Structure. 1999;7:1235–1245. doi: 10.1016/s0969-2126(00)80057-x. [DOI] [PubMed] [Google Scholar]
  • 53.Briknarova K, Gehrmann M, Banyai L, Tordai H, Patthy L, Llinas M. Gelatin-binding region of human matrix metalloproteinase 2: structure, dynamics and function of the Col-23 two-domain construct. J Biol Chem. 2001;276:27613–27621. doi: 10.1074/jbc.M101105200. [DOI] [PubMed] [Google Scholar]
  • 54.Ozhogina OA, Trexler M, Bányai L, Llinás M, Patthy L. Origin of fibronectin type II (FN2) modules. Structural analyses of distantly-related members of the kringle-family identify the kringle-domain of neurotrypsin as a potential link between FN2 domains and kringles. Protein Sci. 2001;10:2114–2122. doi: 10.1110/ps.15801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Gehrmann M, Briknarová K, Bányai L, Patthy L, Llinás M. The Col-1 module of human matrix metalloproteinase-2 (MMP-2): structural/functional relatedness between gelatin-binding fibronectin type II modules and lysine-binding Kringle domains. Biol Chem. 2002;383:137–148. doi: 10.1515/BC.2002.014. [DOI] [PubMed] [Google Scholar]
  • 56.Trexler M, Briknarova K, Gehrmann M, Llinas M, Patthy L. Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2) J Biol Chem. 2003;278:12241–12246. doi: 10.1074/jbc.M210116200. [DOI] [PubMed] [Google Scholar]
  • 57.Gehrmann ML, Douglas JT, Bányai L, Tordai H, Patthy L, Llinas M. Modular autonomy, ligand specificity, and functional cooperativity of the three in-tandem fibronectin type II repeats from human matrix metalloproteinase 2. J Biol Chem. 2004;279:46921–46929. doi: 10.1074/jbc.M408859200. [DOI] [PubMed] [Google Scholar]
  • 58.Ozhogina OA, Grishaev A, Bominaar EL, Patthy L, Trexler M, Llinás M. NMR solution structure of the neurotrypsin Kringle domain. Biochemistry. 2008;47:12290–12298. doi: 10.1021/bi800555z. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Protein Journal are provided here courtesy of Springer

RESOURCES